Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Gusacitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 433,213Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Asana to Present Positive Results from Ph2b Study of Oral JAK/SYK Gusacitinib
    Asana to Present Positive Results from Ph2b Study of Oral JAK/SYK Gusacitinib

    20 Oct 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/asana-biosciences-to-present-positive-results-from-phase-2b-study-of-oral-jak-syk-inhibitor-gusacitinib-in-patients-with-chronic-hand-eczema-in-the-late-breaking-news-session-at-the-eadv-virtual-congress/

    BIOSPACE
    20 Oct 2020
    Share Share
    Asana BioSciences Announces Topline result Ph2b Study Oral JAK/SYK Gusacitinib
    Asana BioSciences Announces Topline result Ph2b Study Oral JAK/SYK Gusacitinib

    02 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200602005492/en

    BUSINESSWIRE
    02 Jun 2020
    Share Share
    Asana BioSciences Announces +ve Topline Results Ph2b Study Oral Gusacitinib
    Asana BioSciences Announces +ve Topline Results Ph2b Study Oral Gusacitinib

    02 Jun 2020

    // TYAHOO

    https://au.news.yahoo.com/asana-biosciences-announces-positive-topline-120000145.html

    TYAHOO
    02 Jun 2020
    Share Share